- Andrea De Luca, Siena University Hospital
- Jean-Claude Desenclos, Institut de Veille Sanitaire
- Susanna Esposito, University of Milan
- Jorge Garbino, University Hospitals Geneva
- Pak Leung Ho, University of Hong Kong
- Sanjeev Krishna, St. George's, University of London
- Jodie McVernon, Melbourne School of Population Health
- Matthew Muller, St. Michael's Hospital, University of Toronto
- Sepehr Tabrizi, The Royal Women's Hospital
- Julian Tang, University Hospitals of Leicester
- Grant Theron, University of Cape Town
- Carlo Torti, University 'Magna Graecia'
- Suzanne Verver, KNCV Tuberculosis Foundation
- Laith Yakob, London School of Hygiene and Tropical Medicine
- Hilary Logan, BioMed Central
This Editorial sets the scene for the series in which we encounter the difficulties of treating antibiotic-resistant gonorrhoea and Mycoplasma genitalium; the continuing spread of chlamydia, syphilis and trichomoniasis, as well as management of non-gonococcal urethritis and bacterial vaginosis.
Fevers in malaria endemic areas can be rapidly tested for malaria, but bacterial and viral infections are not usually distinguished; a test for C-reactive protein may prevent common treatable infections going undiagnosed and reduce overconsumption of antibiotics.
Inappropriate antibiotic therapy is associated with increased mortality and prolonged hospital stays that could translate into higher health care costs, whereas use of appropriate antibiotics improves patient outcomes.
There is a link between psychological distress, alcohol use, health literacy, and clinical morbidity with non-adherence to anti-tuberculosis treatment; use of screening together with counselling could improve patient health and reduce the likelihood of transmission.
Antiretroviral therapy reduces HIV transmission risk, and a systematic review and meta-analysis of the available evidence suggests that sexually transmitted co-infections do not affect the risk of HIV transmission from individuals on antiretroviral therapy.
BMC Infectious Diseases 2015, 15:497
BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
BMC Infectious Diseases is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.
BMC series - open, inclusive and trusted.
BMC series blog
- 01 December 2015
- The BMC Series advent calendar
- 18 November 2015
- Adélie penguins – the climate change winners?
Integrated modeling and management of poliovirus endgame risks and policies
Published: 17 September 2015
Last updated: 24 September 2015
Sexually transmitted infection treatment challenges
Published: 30 July 2015
Last updated: 1 December 2015